CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 78 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $11,000 | -54.2% | 8,255 | +50.1% | 0.00% | 0.0% |
| Q2 2018 | $24,000 | +50.0% | 5,500 | +59.2% | 0.00% | 0.0% |
| Q1 2018 | $16,000 | 0.0% | 3,455 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,000 | -48.4% | 3,455 | -38.0% | 0.00% | 0.0% |
| Q3 2017 | $31,000 | +93.8% | 5,575 | +106.5% | 0.00% | 0.0% |
| Q2 2017 | $16,000 | +300.0% | 2,700 | +285.7% | 0.00% | – |
| Q1 2017 | $4,000 | -50.0% | 700 | -56.2% | 0.00% | – |
| Q4 2016 | $8,000 | +700.0% | 1,600 | +128.6% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 700 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,192,080 | $9,704,000 | 4.11% |
| Ghost Tree Capital, LLC | 219,977 | $1,790,000 | 1.06% |
| JBF Capital, Inc. | 148,178 | $1,205,000 | 0.18% |
| Polar Capital LLP | 900,604 | $7,326,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 80,000 | $651,000 | 0.15% |
| HAMILTON LANE ADVISORS LLC | 33,141 | $270,000 | 0.11% |
| Jasper Ridge Partners, L.P. | 63,996 | $521,000 | 0.03% |
| Weiss Multi-Strategy Advisers LLC | 95,000 | $773,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 550,000 | $4,474,000 | 0.01% |
| AXA S.A. | 292,625 | $2,381,000 | 0.01% |